‘Now I am focused on my recovery’: Former Australian of the Year faces major health battle
By
Maan
- Replies 8
Medical breakthroughs can offer hope where there once was none, pushing the boundaries of what’s possible in modern treatment.
But when a leading expert becomes the patient, the stakes—and the risks—are even higher.
One Australian professor, known for his groundbreaking research, has faced a personal battle with a devastating diagnosis.
Professor Richard Scolyer, who has been undergoing an experimental treatment for brain cancer, recently had a complex surgery following concerning changes detected in his brain.
The 58-year-old Australian of the Year shared the update, revealing that his latest scans showed ‘new changes’ that could either be a result of his previous treatment or a recurrence of his tumour.
‘Unfortunately my recent scans show some new changes which could be an effect of my previous treatment or recurrent brain tumour,’ he said on social media.
Scolyer was initially diagnosed with glioblastoma—an aggressive and incurable form of brain cancer—after suffering a seizure while attending a work conference overseas.
Doctors gave him a prognosis of six to nine months, as the disease has had little progress in treatment over the past two decades.
Determined to change that, he became the first person in the world to undergo pre-surgery combination immunotherapy, a treatment approach adapted from research into melanoma.
He took the risk despite the possibility of it shortening his lifespan, working closely with Professor Georgina Long and her team to explore whether the techniques used for skin cancer could help treat his condition.
Scolyer and Long were recognised for their contributions to medical science and named Australians of the Year in 2024.
His latest operation was performed at Chris O'Brien Lifehouse in Sydney, where he was now focusing on recovery.
‘Now I am focused on my recovery,’ he said, expressing gratitude for the well wishes he had received.
Professor Richard Scolyer’s journey has been one of groundbreaking medical innovation and immense personal risk.
His decision to undergo experimental treatment has sparked global interest in the future of brain cancer research.
Watch the full story to see how he’s challenging the odds.
In a previous story, a brain cancer specialist shared her daily routine to help reduce the risk of the disease.
She revealed the foods she eats and the habits she follows to support brain health.
Read more to discover her expert insights on prevention.
Medical advancements are constantly evolving, but how much risk should patients take for the chance of a breakthrough? Let us know your thoughts in the comments.
But when a leading expert becomes the patient, the stakes—and the risks—are even higher.
One Australian professor, known for his groundbreaking research, has faced a personal battle with a devastating diagnosis.
Professor Richard Scolyer, who has been undergoing an experimental treatment for brain cancer, recently had a complex surgery following concerning changes detected in his brain.
The 58-year-old Australian of the Year shared the update, revealing that his latest scans showed ‘new changes’ that could either be a result of his previous treatment or a recurrence of his tumour.
‘Unfortunately my recent scans show some new changes which could be an effect of my previous treatment or recurrent brain tumour,’ he said on social media.
Scolyer was initially diagnosed with glioblastoma—an aggressive and incurable form of brain cancer—after suffering a seizure while attending a work conference overseas.
Doctors gave him a prognosis of six to nine months, as the disease has had little progress in treatment over the past two decades.
Determined to change that, he became the first person in the world to undergo pre-surgery combination immunotherapy, a treatment approach adapted from research into melanoma.
He took the risk despite the possibility of it shortening his lifespan, working closely with Professor Georgina Long and her team to explore whether the techniques used for skin cancer could help treat his condition.
Scolyer and Long were recognised for their contributions to medical science and named Australians of the Year in 2024.
His latest operation was performed at Chris O'Brien Lifehouse in Sydney, where he was now focusing on recovery.
‘Now I am focused on my recovery,’ he said, expressing gratitude for the well wishes he had received.
Professor Richard Scolyer’s journey has been one of groundbreaking medical innovation and immense personal risk.
His decision to undergo experimental treatment has sparked global interest in the future of brain cancer research.
Watch the full story to see how he’s challenging the odds.
In a previous story, a brain cancer specialist shared her daily routine to help reduce the risk of the disease.
She revealed the foods she eats and the habits she follows to support brain health.
Read more to discover her expert insights on prevention.
Key Takeaways
- Professor Richard Scolyer, 58, had complex surgery after scans revealed possible tumour recurrence or treatment effects.
- He was diagnosed with incurable glioblastoma after suffering a seizure while overseas and was initially given six to nine months to live.
- Scolyer became the first patient to receive pre-surgery combination immunotherapy, an experimental treatment based on melanoma research, despite the risks involved.
- He was now recovering at Chris O'Brien Lifehouse in Sydney and expressed gratitude for the support he had received.
Medical advancements are constantly evolving, but how much risk should patients take for the chance of a breakthrough? Let us know your thoughts in the comments.